enVVeno Medical Corporation (NVNO)

enVVeno Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2.31	3.62	4.56	54.73	9.33	2.12
Short-Term Investments	40.63	42.79	34.49	0	0	0
Cash & Cash Equivalents	42.94	46.41	39.04	54.73	9.33	2.12
Cash Growth	25.54%	18.87%	-28.66%	486.29%	340.87%	-22.74%
Other Current Assets	0.31	0.51	0.39	0.31	0.23	-0.69
Total Current Assets	43.25	46.92	39.44	55.04	9.57	1.42
Property, Plant & Equipment	1.55	1.68	2.19	2.61	0.94	1.17
Other Long-Term Assets	0.03	0.03	0.03	0.05	0.03	0.84
Total Long-Term Assets	1.58	1.71	2.23	2.66	0.97	2.01
Total Assets	44.83	48.64	41.66	57.7	10.54	3.43
Accounts Payable	1.14	1.03	1.22	0.56	1.39	1.22
Deferred Revenue	0	0	0	0	0	0.03
Current Debt	0.34	0.34	0.31	0.29	0.63	0.29
Other Current Liabilities	0	0	0	0.73	1.17	0.33
Total Current Liabilities	1.49	1.37	1.53	1.58	3.19	1.88
Long-Term Debt	0.97	1.06	1.4	1.72	0.25	0.57
Total Long-Term Liabilities	0.97	1.06	1.4	1.72	0.25	0.57
Total Liabilities	2.46	2.44	2.93	3.3	3.44	2.44
Total Debt	1.32	1.4	1.72	2.01	0.88	0.86
Debt Growth	-19.55%	-18.30%	-14.46%	127.79%	2.80%	-
Retained Earnings	-135.03	-130.04	-106.52	-81.85	-65.32	-56.19
Shareholders' Equity	42.37	46.2	38.73	54.4	7.1	0.99
Net Cash / Debt	41.63	45.01	37.33	52.72	8.45	1.26
Net Cash / Debt Growth	27.80%	20.58%	-29.20%	523.64%	570.60%	-54.00%
Net Cash Per Share	2.59	3.66	3.32	6.07	6.55	2.00
Working Capital	41.76	45.55	37.91	53.46	6.38	-0.45
Book Value Per Share	2.64	3.76	3.45	6.27	5.50	1.57

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).